« Back to Record
Zhu, A. X., & Verset, G. (2018). Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. Lancet oncology, 19(9), e440. doi:10.1016/S1470-2045(18)30351-6
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290727



